SCHEMBL4559573

SCHEMBL4559573

CCCCCCCCCCCCCCCCCCCC=C(O)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.69
PPARG P37231 4/20 0.50
PPARA Q07869 4/20 0.50
TERT O14746 3/20 0.50
PTPN1 P18031 3/20 0.50
PPARD Q03181 3/20 0.50
TOP1 P11387 3/20 0.50
MAPT P10636 2/20 0.50
BLM P54132 2/20 0.50
HSD17B10 Q99714 2/20 0.50
FABP4 P15090 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX15 P16050 1/20 0.50
APEX1 P27695 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3269915 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL3794261 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL4559570 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL3682579 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL4559828 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL4559831 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL3794524 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL2020730 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL1151027 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1
SCHEMBL2020733 1.00 EP300 (0.69) EP300PPARGPPARATERTPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4368686-B1 LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF CHINA PETROLEUM & CHEM CORP (CN) 2026-05-27 EP disclosed
US-12365847-B2 Lubricity improver composition for fuel oil and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2025-07-22 US disclosed
US-20240368490-A1 LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF Sinopec Research Institute of Petroleum Processing Co., Ltd. (CN) 2024-11-07 US disclosed
EP-4368686-A1 LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF China Petroleum & Chemical Corporation (CN) 2024-05-15 EP disclosed
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2022-05-10 US disclosed
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed
EP-3315531-A1 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY Xiamen Sinopeg Biotech Co., Ltd. (CN) 2018-05-02 EP disclosed
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2017-11-02 US disclosed
CN-104877127-A Eight-armed polyethylene glycol derivative, preparation method and related biological substance modified by derivative XIAMEN SINOPEG BIOTECH CO LTD 2015-09-02 CN disclosed
US-20090209485-A1 MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES PARISH CHRISTOPHER RICHARD 2009-08-20 US disclosed
CN-101203230-A Modulation of angiogenesis with NOD factors such as glucosamine oligosaccharides RICHARD PARISH CHRISTOPHER (AU) 2008-06-18 CN disclosed
EP-1871392-A1 MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES Parish, Christopher Richard (AU) 2008-01-02 EP disclosed
WO-2006102717-A1 MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES PARISH CHRISTOPHER RICHARD (AU) 2006-10-05 WO disclosed
US-5517228-A Apparatus for displaying a recording medium sheet and printing an image thereon RICOH CO., LTD. (JP) 1996-05-14 US disclosed
US-5154748-A Sphingophospholipids containing inositol, and their application as inducers of resistance to various cryptogamic diseases in plants INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) 1992-10-13 US disclosed
US-4981618-A Sphingophospholipids containing inositol, their production, and their application as inducers of resistance to various cryptogamic diseases in plants INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) 1991-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, MRPS18A EP300 4722/4885PPARG 3105/4885PPARA 3736/4885
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, COG8 EP300 4795/4885PPARG 3829/4885PPARA 4133/4885
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 EP300 4722/4885PPARG 3625/4885PPARA 4078/4885
US-20090209485-A1 MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES FLT4, UGGT1, FLT1 EP300 2954/4885PPARG 1632/4885PPARA 2821/4885
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor HDGF, F11, F12 EP300 2828/4885PPARG 2792/4885PPARA 3187/4885
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR HDGF, F11, F12 EP300 2828/4885PPARG 2792/4885PPARA 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.